TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35969436

Group type: EXPERIMENTAL
Intervention: Reminder group (daily reminders via WeChat)
Number of subjects: 716

Group type: COMPARATOR
Intervention: No-reminder group (no reminders)
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Reminder group
Number of subjects: 716
Study: 34533505

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) algorithm for predicting unplanned subsequent surgery after intramedullary nailing (IMN) for TSFs
Number of subjects: 1198
Study: 35945566

Group type: EXPERIMENTAL
Intervention: IV alteplase (5mg) followed by continuous IV infusion of m‐proUK (40 mg/h during 60 min)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care with alteplase (0.9 mg/kg)
Number of subjects: 200
Study: 33805908

Group type: EXPERIMENTAL
Intervention: Tetrodotoxin (TTX) 30 µg BID
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 35549912

Group type: EXPERIMENTAL
Intervention: HIPEC with high-dose mytomicin-C (35 mg/m2)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Personalized systemic chemotherapy (both arms)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (without HIPEC)
Number of subjects: 216
Study: 32234275

Group type: EXPERIMENTAL
Intervention: Telehealth delivery of the dyadic intervention program
Number of subjects: 63

Group type: COMPARATOR
Intervention: Home visit delivery of the dyadic intervention program
Number of subjects: 63
Study: 35688358

Group type: EXPERIMENTAL
Intervention: Pimitespib 160 mg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Pimitespib (cross-over adjusted)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (cross-over adjusted)
Number of subjects: 86
Study: 34210228

Group type: EXPERIMENTAL
Intervention: EPA and DHA supplementation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 84
Study: 32789809

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim-cbqv
Number of subjects: 122

Group type: COMPARATOR
Intervention: Pegfilgrastim
Number of subjects: 122
Study: 35999163

Group type: EXPERIMENTAL
Intervention: Polaprezinc
Number of subjects: 224

Group type: COMPARATOR
Intervention: Rebamipide
Number of subjects: 224
Study: 34956918

Group type: EXPERIMENTAL
Intervention: Levothyroxine taken at dusk 30-min before Iftar meal (group 1)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Levothyroxine taken 3 or more hours after Iftar meal (group 2)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Levothyroxine taken at dawn 30-min before Suhur meal (group 3)
Number of subjects: 148
Study: 32658298

Group type: EXPERIMENTAL
Intervention: CBT delivered via telemedicine (CBT-TM)
Number of subjects: 65

Group type: COMPARATOR
Intervention: CBT delivered face-to-face (CBT-F2F)
Number of subjects: 65
Study: 32019699

Group type: EXPERIMENTAL
Intervention: Fully automatic, deep learning‐based segmentation algorithm
Number of subjects: 62

Group type: COMPARATOR
Intervention: Semiautomatic measurements by expert readers
Number of subjects: 62
Study: 36209381

Group type: EXPERIMENTAL
Intervention: Topical application of triamcinolone acetonide after fractional CO2 laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical application of triamcinolone acetonide after microneedling (MN) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Microneedling (MN)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study: 34562648

Group type: EXPERIMENTAL
Intervention: 5-Aminolaevulinic Acid Photodynamic Therapy (ALA PDT)
Number of subjects: 277

Group type: COMPARATOR
Intervention: CO2 laser therapy
Number of subjects: 277
Study: 35863669

Group type: EXPERIMENTAL
Intervention: Prednisolone (0.5 mg/kg/d, maximum 40 mg/d, for 14 ± 2 days)
Number of subjects: 27
Study: 32493401

Group type: EXPERIMENTAL
Intervention: GKT137831
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35561566

Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 300
Study: 34294595

Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg intravenously every 2 weeks for 12 months)
Number of subjects: 713

Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 713

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study: 34987000

Group type: EXPERIMENTAL
Intervention: Choose Your Own Adventure (CYOA) presentation format
Number of subjects: 144

Group type: COMPARATOR
Intervention: Linear case format
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both formats
Number of subjects: 144
Study: 34423354

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lignocaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fentanyl and Lignocaine
Number of subjects: 70
Study: 32967873

Group type: EXPERIMENTAL
Intervention: Intravenous haloperidol 2.5 mg every 8 hours, titrated to a maximum of 5 mg every 8 hours until delirium resolution or ICU discharge.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study: 35501469

Group type: EXPERIMENTAL
Intervention: Real cerebellar tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham cerebellar tDCS
Number of subjects: 20
Study: 34181750

Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/day for 10 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: COMPARATOR
Intervention: Budesonide and Placebo (post hoc analysis)
Number of subjects: 37
Study: 36041308

Group type: EXPERIMENTAL
Intervention: Knee extensor muscle steadiness (measured as coefficient of variance [%] and peak power frequency [Hz])
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Coefficient of variance of muscle steadiness
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Peak power frequency of muscle steadiness
Number of subjects: 177
Study: 34723163

Group type: EXPERIMENTAL
Intervention: C21 (100 mg bid for 7 days)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: C21
Number of subjects: 106
Study: 35409775

Group type: EXPERIMENTAL
Intervention: E-training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Face-to-face training
Number of subjects: 100
Study: 33548494

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 32797089

Group type: EXPERIMENTAL
Intervention: Deep neural network for diagnosing MR images of tumors of the hand
Number of subjects: 221

Group type: COMPARATOR
Intervention: Ground truth analysis and manual analysis by a radiologist
Number of subjects: 221
Study: 33656188

Group type: EXPERIMENTAL
Intervention: 3D printed facial flap simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional paper facial flap exercise (Control)
Number of subjects: 0
Study: 33040002

Group type: EXPERIMENTAL
Intervention: Febuxostat (hyperuricaemia treatment)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 548
Study: 32598683

Group type: EXPERIMENTAL
Intervention: NSAIDs + Injectran (Chondroitin sulfate) 200 mg I.M. every other day No. 25
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: NSAIDs + Fermatron 1% 2 ml I.A. with an interval of 7 days No. 3
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: NSAIDs + Injectran 200 mg I.M. every other day No. 25 + Fermatron 1% 2 ml I.A. with an interval of 7 days No. 3
Number of subjects: 125

Group type: COMPARATOR
Intervention: NSAIDs (control group)
Number of subjects: 125
Study: 35091707

Group type: EXPERIMENTAL
Intervention: Cystotome-assisted prechop phacoemulsification surgery (CAPPS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 64
Study: 33839890

Group type: EXPERIMENTAL
Intervention: Endoscopic clipping closure after colorectal ESD
Number of subjects: 155

Group type: COMPARATOR
Intervention: Non-closure after colorectal ESD
Number of subjects: 155
Study: 32204146

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 35603597

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tenecteplase
Number of subjects: 0
Study: 32871505

Group type: EXPERIMENTAL
Intervention: High social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 0
Study: 35157497

Group type: EXPERIMENTAL
Intervention: Activity monitoring with triage visits triggered by a 20% decrease in daily steps or 20% increase in heart rate.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Activity monitoring with triage visits.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Observation group (no active monitoring).
Number of subjects: 40
Study: 33880614

Group type: EXPERIMENTAL
Intervention: TRS2�P risk scoring system
Number of subjects: 2611
Study: 33582664

Group type: EXPERIMENTAL
Intervention: Colchicine (2 mg oral bolus followed by 0.5 mg b.i.d. for 5 days)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 194
Study: 33789792

Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 15% with fracture angle (FA) of 40°
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 15% with fracture angle (FA) of 60°
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 20% with fracture angle (FA) of 40°
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 25% with fracture angle (FA) of 40°
Number of subjects: 12
Study: 36163722

Group type: EXPERIMENTAL
Intervention: Curcumin 500 mg per oral capsule twice daily for 1 month plus nutritional standard of care (SOC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nutritional standard of care (SOC) only
Number of subjects: 30
Study: 32003750

Group type: EXPERIMENTAL
Intervention: Precious app with digitalized motivational interviewing and gamification
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Precious app
Number of subjects: 12
Study: 33606431

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 86

Group type: COMPARATOR
Intervention: Chloral hydrate
Number of subjects: 86
Study: 36338456

Group type: EXPERIMENTAL
Intervention: Systemic decolonization (topical chlorhexidine gluconate, intranasal mupirocin, oral rifampin, and oral doxycycline)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard decolonization (topical chlorhexidine gluconate and intranasal mupirocin)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard decolonization
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Systemic decolonization
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Systemic decolonization vs Standard decolonization
Number of subjects: 98
Study: 34371442

Group type: EXPERIMENTAL
Intervention: Maintenance of androgen deprivation therapy (ADT)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Intermittent docetaxel administration
Number of subjects: 198

Group type: COMPARATOR
Intervention: Suspension of androgen deprivation therapy (ADT)
Number of subjects: 198
Study: 33212360

Group type: EXPERIMENTAL
Intervention: Decision support intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 110
Study: 32438639

Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ), 16 ounces daily for 24 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 36404282

Group type: EXPERIMENTAL
Intervention: Adapted group cognitive-behavioral therapy (CBT) program
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 66
Study: 33452722

Group type: EXPERIMENTAL
Intervention: Proposed 3D real-time MRI method using randomized, variable-density, stack-of-spiral sampling
Number of subjects: 2

Group type: COMPARATOR
Intervention: Original 3D real-time MRI method
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Proposed 3D real-time MRI method
Number of subjects: 2
Study: 32732374

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 35
Study: 35868017

Group type: EXPERIMENTAL
Intervention: LOW‐HIIT (n=13), consisting of 5 × 1 min cycle ergometer intervals (14 min per session total duration) at 80% to 95% HR peak (two sessions per week for 12 wk)
Number of subjects: 27

Group type: COMPARATOR
Intervention: SHAM (n=14), performing light physical mobilization exercises
Number of subjects: 27
Study: 35612762

Group type: EXPERIMENTAL
Intervention: Statins (STA trial)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLAC trial)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (EXER+STA and EXER+PLAC trials)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Statins withdrawal
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 21
Study: 32075665

Group type: EXPERIMENTAL
Intervention: Twice-weekly haemodialysis sessions
Number of subjects: 88

Group type: COMPARATOR
Intervention: Thrice-weekly haemodialysis regimen
Number of subjects: 88
Study: 36342245

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 174

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 174
Study: 33016677

Group type: EXPERIMENTAL
Intervention: Mexidol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 32346715

Group type: EXPERIMENTAL
Intervention: Immediate implantation after minimally invasive extraction
Number of subjects: 86

Group type: COMPARATOR
Intervention: Delayed implantation after minimally invasive extraction
Number of subjects: 86
Study: 36352473

Group type: EXPERIMENTAL
Intervention: DISCOVER intervention (school-based stress workshop programme)
Number of subjects: 0
Study: 33507684

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical hysterectomy (LRH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 30
Study: 32252619

Group type: EXPERIMENTAL
Intervention: Kinesio taping with trunk rehabilitation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo taping with trunk rehabilitation
Number of subjects: 28
Study: 35771894

Group type: EXPERIMENTAL
Intervention: Condom use during last sexual intercourse
Number of subjects: 600

Group type: COMPARATOR
Intervention: Experiencing physical violence by sexual partners
Number of subjects: 600

Group type: COMPARATOR
Intervention: Ever using drugs of addiction
Number of subjects: 600
Study: 34931773

Group type: EXPERIMENTAL
Intervention: 3D-printed implant overdentures
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional implant overdentures
Number of subjects: 28
Study: 32340632

Group type: EXPERIMENTAL
Intervention: Cannabis containing Δ‐9‐tetrahydrocannabinol (THC) and negligible levels of CBD (Cann-CBD)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Cannabis containing THC and CBD (Cann+CBD)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Cann-CBD
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 32659510

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 1272
Study: 616191207

Group type: EXPERIMENTAL
Intervention: Fatigue management education (six topics: pain management, nutrition management, sleep hygiene, anxiety management, light exercise, energy conservation)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Nursing care standard (control group)
Number of subjects: 81
Study: 35351693

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34784131

Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite with lidocaine (CaHA (+); Radiesse&reg; (+))
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (delayed treatment)
Number of subjects: 180
Study: 35486418

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy for insomnia (ICBT‐i)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Applied relaxation (active control)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Both ICBT‐i and applied relaxation
Number of subjects: 54
Study: 33826992

Group type: EXPERIMENTAL
Intervention: Written expressive disclosure (WED) about IBS
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Written expressive disclosure (WED) (combined group)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (writing about daily activities)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: All groups (WED and control)
Number of subjects: 189
Study: 34534130

Group type: EXPERIMENTAL
Intervention: Sepsis Transition And Recovery support (n = 349)
Number of subjects: 691

Group type: COMPARATOR
Intervention: Usual care alone (n = 342)
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: Sepsis Transition And Recovery support
Number of subjects: 691

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 691
Study: 33533532

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVS)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 131
Study: 32392279

Group type: EXPERIMENTAL
Intervention: Higher body mass index (BMI)
Number of subjects: 379708

Group type: EXPERIMENTAL
Intervention: Higher waist-hip ratio
Number of subjects: 379708

Group type: EXPERIMENTAL
Intervention: Genetic liability of type 2 diabetes (highest quartile)
Number of subjects: 379708
Study: 35162424

Group type: EXPERIMENTAL
Intervention: Automated segmentation using U-Net convolutional neural network (CNN)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Automated segmentation using U-Net CNN
Number of subjects: 150
Study: 33392952

Group type: EXPERIMENTAL
Intervention: Momentary increases in stress appraisal
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Stress appraisal ratings of 0.50 SD higher than average
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Every 0.25 increments in momentary stress appraisal
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Work/school stressors and interpersonal stressors
Number of subjects: 37
Study: 32534135

Group type: EXPERIMENTAL
Intervention: Review group (expert panel recommendations)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Nonreview group (referring surgeon's preference)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Overall recommendations from surgeons
Number of subjects: 114
Study: 35842062

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) therapy with pneumatic cuff set to 80% limb occlusion pressure, performed 5 days per week for two weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both BFR and control groups
Number of subjects: 45
Study: 34834540

Group type: COMPARATOR
Intervention: Standard escitalopram dosing
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Dosing based on validated CYP2C19 phenotypes for escitalopram metabolism
Number of subjects: 132
Study: 35168915

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist-led smartphone application plus usual care
Number of subjects: 124
Study: 36011930

Group type: EXPERIMENTAL
Intervention: HEUR-L (heuristic learning)
Number of subjects: 28

Group type: COMPARATOR
Intervention: PRES-T (prescriptive teaching)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: HEUR-L
Number of subjects: 28

Group type: COMPARATOR
Intervention: PRES-T
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: HEUR-L and PRES-T
Number of subjects: 28
Study: 32011181

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (300 mg of corn-starch)
Number of subjects: 22
Study: 35477683

Group type: EXPERIMENTAL
Intervention: rds-ccPAS-1500 (1500 pulses per session)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: rds-ccPAS-750 (750 pulses per session)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single-site stimulation over the right dlPFC (1500 pulses per session)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single-site stimulation over the right PPC (1500 pulses per session)
Number of subjects: 50
Study: 32533264

Group type: EXPERIMENTAL
Intervention: Immediate loading of strategic mini-implants
Number of subjects: 76

Group type: COMPARATOR
Intervention: Delayed loading of strategic mini-implants
Number of subjects: 76
Study: 36092959

Group type: EXPERIMENTAL
Intervention: Antimicrobial step‐down therapy (imipenem/cilastatin)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional antimicrobial therapy (sulbactam plus cefoperazone)
Number of subjects: 65
Study: 32779012

Group type: EXPERIMENTAL
Intervention: Static-guided (SG) access group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 34331838

Group type: EXPERIMENTAL
Intervention: Nebulization and meibomian gland massage (NB group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Eye drop group (ED group)
Number of subjects: 38
Study: 33288477

Group type: EXPERIMENTAL
Intervention: Geri-medium
Number of subjects: 181

Group type: COMPARATOR
Intervention: CSCM
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (Geri-medium)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Preimplantation genetic testing for aneuploidy (CSCM)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Untested transfers (Geri-medium)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Untested transfers (CSCM)
Number of subjects: 181
Study: 36205225

Group type: EXPERIMENTAL
Intervention: PARTNER intervention (centralised Care Support Team for 12 months)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 217